Basic Information
| LncRNA/CircRNA Name | DUXAP8 |
| Synonyms | NA |
| Region | GRCh38_22:15784959-15829984 |
| Ensemble | ENSG00000206195 |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | renal cell carcinoma |
| ICD-0-3 | C64.9 |
| Methods | Microarray, qPCR, RNAi etc. |
| Sample | renal cell carcinoma tissues |
| Expression Pattern | up-regulated |
| Function Description | knockdown of DUXAP8 could impair RCC cells invasive ability in vitro. lots of lncRNAs expression levels are significantly associated RCC patients overall survival time, such as PVT1 and DUXAP8 . |
| Pubmed ID | 29152119 |
| Year | 2017 |
| Title | A genome-wide comprehensively analyses of long noncoding RNA profiling and metastasis associated lncRNAs in renal cell carcinoma. |
External Links
| Links for DUXAP8 | GenBank HGNC NONCODE |
| Links for renal cell carcinoma | OMIM COSMIC |